TGA seeks feedback on proposed changes to compounded medicines guidelines The Therapeutic Goods Administration is seeking submissions from interested parties on its proposed changes to compounded medicine manufacturing practices and procedures. The current guidance for compound medicine manufacturers was published in 2017. Now, following updates to pharmaceutical manufacturing principles in July 2020, and the receipt of
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.